Assay of functional plasminogen in rat plasma applicable to experimental studies at thrombolysis

Thrombosis and Haemostasis

Volumn 84, Issue 2, 2000, Pages 299-306

  Bangert, Kristian ^b   Thorsen, Sixtus ^a  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

Assay; Plasminogen; Rat

Indexed keywords

ALPHA 2 MACROGLOBULIN; ANILIDE; PLASMIN; PLASMINOGEN; TRANEXAMIC ACID; UROKINASE;

ARTICLE; BLOOD CLOT LYSIS; CALIBRATION; ENZYME KINETICS; HYDROLYSIS; MALE; NONHUMAN; PLASMA; PLASMINOGEN ACTIVATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT;

EID: 0033859699     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614011     Document Type: Article

References (45)

1. Wiman B, Hamsten A. The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease. Semin Thromb Hemost 1990; 16: 207-16.
2. Lijnen HR, Bachmann F, Collen D, Ellis V, Pannekoek H, Rijken DC, Thorsen S. Mechanisms of plasminogen activation. J Intern Med 1994; 236: 415-24.
3. Chapman HA. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 1997; 9: 714-24.
4. Blasi F. uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? Immunol Today 1997; 18: 415-7.
5. Thorsen S. Müllertz S, Suenson E, Kok P. Sequence of formation of molecular forms of plasminogen and plasmin-inhihitor complexes in plasma activated by urokinase or tissue-type plasminogen activator. Biochem J 1984; 223: 179-87.
6. Degen SJF, Bell SM, Schaefer LA, Elliott RW. Characterization of the cDNA coding for mouse plasminogen and localization of the gene to mouse chromosome 17. Genomics 1990; 8: 49-61.
7. Bangert K. Rattus norvegicus mRNA for plasminogen protein. [AJ242649]. 1999. EMBL Nucleotide Sequence Database.
8. Petersen LC, Brender J, Suenson E. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation. Biochem J 1985; 225: 149-58.
9. Markus G. Conformational changes in plasminogen, their effect on activation, and the agents that modulate activation rates - A review. Fibrinolysis 1996; 10: 75-85.
10. Thorsen S, Kok P, Astrup T. Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to epsilon-aminocaproic acid. Thromb Diath Haemorrh 1974; 32: 325-40.
11. Kulseth MA, Helgeland L. A highly sensitive chromogenic microplate assay for quantification of rat and human plasminogen. Anal Biochem 1993; 210: 314-7.
12. Owens MR, Cimino CD. Biosynthesis of plasminogen by the perfused rat liver. J Lab Clin Med 1985; 105: 368-73.
13. Mussoni L, Raczka E, Chmielewska J, Donati MB, Latallo ZS. Plasminogen assay in rabbit, rat and mouse plasma using the chromogenic substrate S-2251. Thromb Res 1979; 15: 341-9.
14. Gram J, Jespersen J. A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples. Thromb Haemost 1985; 53: 255-9.
15. Baillie AJ, Sim AK. Activation of the fibrinolytic enzyme system in laboratory animals and in man. Thromb Diath Haemorrh 1971; 25: 499-506.
16. Bangert K, Johnsen AH, Thorsen S. Characterization and assay of rat plasminogen (PG). Thromb Haemost 1997; Supplement: 560-0.
17. Philips M, Juul A-G, Selmer J, Lind B, Thorsen S. A specific immunologic assay for functional plasminogen activator inhibitor 1 in plasma - standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic disease. Thromb Haemost 1992; 68: 486-94.
18. Kyhse-Andersen J. Semidry Electroblotting - Transfer Using Equipment Without Buffer Vessel. In: CRC Handbook of Immunoblotting of Proteins. Bjerrum OJ, Heegaard NHH, eds. Boca Raton, Florida: CRC Press 1988; 79-85.
19. 2-plasmin inhibitor in human plasma. Biochem J 1993; 291: 623-5.
20. Thorsen S, Clemmensen I, Sottrup-Jensen L, Magnusson S. Adsorption to fibrin of native fragments of known primary structure from human plasminogen. Biochim Biophys Acta 1981; 668: 377-87.
21. Müllertz S, Thorsen S, Sottrup-Jensen L. Identification of molecular forms of plasminogen and plasmin-inhihitor complexes in urokinase-activated human plasma. Biochem J 1984; 223: 169-77.
22. Ipsen H-H, Christensen U. Kinetic studies of urokinase-catalysed hydrolysis of 5-oxo-1-prolylglycyl-1-arginine 4-nitroanilide. Biochim Biophys Acta 1980; 613: 476-81.
23. Petersen LC, Boel E, Johannessen M, Foster D. Quenching of the amidolytic activity of one-chain tissue-type plasminogen activator by mutation of lysine-416. Biochemistry 1990; 29: 3451-7.
24. Thorsen S, Müllertz S. Rate of activation and clectrophoretic mobility of unmodified and partially degraded plasminogen. Scand J Clin Lab Invest 1974; 34: 167-76.
25. Ganrot PO. On the determination of molar concentrations of plasmin and plasmin inhibitors. Acta Chem Scand 1967; 21: 595-601.
26. Collen D, Van Hoef B, Schlott B, Hartmann M, Gührs K-H, Lijnen HR. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase. Eur J Biochem 1993; 216: 307-14.
27. Christensen U, Ipsen H-H. Steady-state kinetics of plasmin-and trypsin-catalysed hydrolysis of a number of tripeptide-p-nitroanilides. Biochim Biophys Acta 1979; 569: 177-83.
28. Lottenherg R, Christensen U, Jackson CM, Coleman PL. Assay of coagulation proteases using peptide chromogenic and fluovogenic substrates. Methods Enzymol 1981; 80: 341-61.
29. Kiss I, Aurell L, Pozsgay M, Elodi P. Investigation on the substrate specificity of human plasmin using tripeptidyl-p-nitroanilide substrates. Biochem Biophys Res Commun 1985; 131: 928-34.
30. Lijnen HR, Van Hoef B, Collen D. Influence of cyanogen-bromide-digested fibrinogenon the kinetics of plasminogen activation by urokinase. Eur J Biochem 1984; 144: 541-4.
31. Cantor CR, Schimmel PR. Absorption Spectroscopy. In: Biophysical Chemistry. San Franciso, CA: W. H. Freeman and Company 1980: 374-85.
32. Wallén P, Wiman B. Characterization of human plasminogen. 1. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations. Biochim Biophys Acta 1970; 221: 20-30.
33. 2-macroglobulin. Biochemistry 1984; 23: 105-11.
34. Lonberg-Holm K, Reed DL, Roberts RC. Damato-McCahe D. Three high molecular weight protease inhibitors of rat plasma. Reactions with trypsin. J Biol Chem 1987; 262: 4844-53.
35. Webb DJ, Crookston KP, Figler NL, LaMarre J, Gonias SL. Differences in the binding of transforming growth factor β1 to the acute-phase reactant and constitutively synthesized α-macroglobulins of rat. Biochem J 1995; 312: 579-86.
36. 2-antiplasmin production. J Clin Invest 1996; 97: 2478-84.
37. 2-plasmin inhibitor. Biochem J 1981; 199: 121-7.
38. Peterson GL. Determination of total protein. Methods Enzymol 1983; 91: 95-119.
39. 2-plasmin inhibitor to plasminogen. Biochim Biophys Acta 1988; 952: 1-7.
40. Weitz JI, Leslie B, Ginsberg J. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis. J Clin Invest 1991; 87: 1082-90.
41. Suenson E, Lûtzen O, Thorsen S. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. Eur J Biochem 1984; 140:513-22.
42. Suenson E, Petersen LC. Fibrin and plasminogen structures essential to stimulation of plasmin formation hy tissue-type plasminogen activator. Biochim Biophys Acta 1986; 870: 510-9.
43. Suenson E, Thorsen S. The course and prerequisites of lys-plasminogen formation during fibrinolysis. Biochemistry 1988; 27: 2435-43.
44. Stewart RJ, Fredenburgh JC, Weitz JI. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E. J Biol Chem 1998; 273: 18292-9.
45. Thorsen S, Müllertz, S. Reaction Sequences and the Mechanism of Plasminogen Activation in Urokinase-Activated Plasma. Effects of Fibrin and 6-Aminohexanoic Acid. In: Progress in Chemical Fibrinolysis and Thrombolysis. Davidson JF, Cepelák V, Samama MM, Desnoyers PC, eds. Edinburgh: Churchill Livingstone 1979; 462-8.